DANIEL EMERY: Open Payments
NPI 1154988921 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 48 payments from 13 companies in 2025. Trend: 2023 $1,058 · 2024 $1,155 · 2025 $977
Food & beverage: $977
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $207 |
| PFIZER INC. | 8 | $183 |
| Amgen Inc. | 5 | $115 |
| AstraZeneca Pharmaceuticals LP | 5 | $108 |
| Exact Sciences Corporation | 3 | $79 |
| Astellas Pharma US Inc | 3 | $74 |
| Novo Nordisk Inc | 3 | $64 |
| Lundbeck LLC | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
Products named: ELIQUIS, UBRELVY, Veozah, REPATHA, QULIPTA, Cologuard Collection Kit, PREVNAR 20, OTEZLA.
Industry payments across VA — which companies pay providers there.
